Wish List

We deliver customized Volume and Quality products to our customers across the world.

Development Pipeline 1

Disclaimer : Metrochem API Pvt Ltd respects the intellectual property rights of others. Some of the Active Pharmaceuticals Ingredients (APIs) listed in the Metrochem’s product list or brochure or in the product list uploaded in Metrochem’s website may be protected by a valid patent in India or in any other countries concerned. However, mentioning of the name of such product(s) in the product brochure or the product list shall not be construed as infringement in any manner whatsoever. Without prejudice to the foregoing, Metrochem’s supply of API being protected by a valid product patent, if any, is intended solely for uses reasonably relating to the development and submission of information required under any law for the time being inforce, in India, or in a country other than India that regulates the manufacture, use, sale or import of the said product, strictly under the conditions as set forth in Section 107A of the Indian patents Act, 1970, as amended in 2005, or an equivalent provision (Bolar exemption) thereof in a country other than India. The disclaimer is applicable till the expiration of the corresponding product patent(s), if any, in the respective. countries concerned.  None of the products will be supplied to the countries wherein this could be in conflict with existing laws. However, the final responsibility lies exclusively with the buyer/ultimate customer.

WISH LIST

S. NOPRODUCT NAMELAB VALIDATIONSCALE UPPROCESS VALIDATIONTHERAPEUTIC CATEGORYCAS NUMBER
1Acotiamide HydrochlorideDevelopment Pipeline 2Gastroprokinetic773092-05-0
2Fenticonazole NitrateDevelopment Pipeline 2Antifungal73151-29-8
3Lercanidipine HydrochlorideDevelopment Pipeline 2Antihypertensive’s132866-11-6
4EfinaconazoleDevelopment Pipeline 2Antifungal164650-44-6
5EpalrestatDevelopment Pipeline 2Diabetic neuropathy82159-09-9
6GliclazideDevelopment Pipeline 2Antidiabetic21187-98-4
7LifitegrastDevelopment Pipeline 2Dry Eye Disease1025967-78-5
8Omecamtiv MecarbilDevelopment Pipeline 2Chronic Heart Failure873697-71-3
9RimegepantDevelopment Pipeline 2Antimigraine1289023-67-1
10SiponimodDevelopment Pipeline 2Multiple sclerosis1230487-00
11Upadacitinib TartrateDevelopment Pipeline 2Antirheumatic1607431-21-9
12BrexpiprazoleDevelopment Pipeline 2Antipsychotic913611-97-9
13BrivaracetamDevelopment Pipeline 2Antiepileptic357336-20-0
14CandesartanDevelopment Pipeline 2Antirheumatic139481-59-7
15EzetimibeDevelopment Pipeline 2Antihyperlipidemic163222-33-1
16FaropenemDevelopment Pipeline 2Antibiotic122547-49-3
17Ferric maltolDevelopment Pipeline 2Antianemic 33725-54-1
18FexuprazanDevelopment Pipeline 2Antiulcerative1902954-60-2
19L-GlutamineDevelopment Pipeline 2Sickle Cell Anemia56-85-9
20LisinoprilDevelopment Pipeline 2Antihypertensive76547-98-3
21MavacamtenDevelopment Pipeline 2Hypertrophic Cardiomyopathy1642288-47-8
22NiclosamideDevelopment Pipeline 2Anthelmintic50-65-7
23PonesimodDevelopment Pipeline 2Multiple Sclerosis/Immunomodulator 854107-55-4
24RelugolixDevelopment Pipeline 2Uterine Leiomyoma737789-87-6
25RivaroxabanDevelopment Pipeline 2Antithrombotic / Anticoagulant366789-02-8
26SelexipagDevelopment Pipeline 2Pulmonary Artery Hypertension475086-01-2
27TegoprazanDevelopment Pipeline 2Antiulcerative942195-55-3
28VericiguatDevelopment Pipeline 2Heart Failure
1350653-20-1
29VibegronDevelopment Pipeline 2Overactive Bladder1190389-15
Close Menu